1093 — CSPC PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00- HK$96.15bn
- HK$77.27bn
- CNY26.01bn
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: CSPC Pharmaceutical Says Phase II Trial Of SYH2066 Officially Initiated In China
Brief: CSPC Pharmaceutical Says Phase I Clinical Trial Of SYH2083 Eye Drops Initiated In China
Brief: CSPC Pharmaceutical Says SYS6062 Obtains Clinical Trial Approval In China
Brief: CSPC Pharmaceutical Says SYS6088 Injection Obtains Clinical Trial Approval In China
Cspc Hits 5: week high on US FDA's nod on herpes zoster vaccine trial
Brief: CSPC Pharmaceutical Initiates Phase IB Clinical Trial Of JMT206 Injection In China
Brief: Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval In U.S.
Brief: Cspc Pharmaceutical's Sys6077 Injection Obtains Clinical Trial Approval In China
Brief: CSPC Pharmaceutical Says Phase III Trial Of Becotatug Achieves Positive Topline Results
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of HB1801 For Advanced Breast Cancer In China
Brief: Cspc Pharmaceutical Says SYS6010 Granted Breakthrough Therapy Designation By NMPA
Brief: CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval In China
Brief: CSPC Pharmaceutical Says Goserelin Sustained-Release Injection Gets Clinical Trial Approval In China
Brief: CSPC Pharmaceutical Says SYH2083 Eye Drops Obtain Clinical Trial Approval In China
Brief: CSPC Pharmaceutical Initiates Phase I Clinical Trial Of SYH2056 Tablets In China